Preparedness Through Respiratory Virus Epidemiology and Community Engagement

Not yet recruitingOBSERVATIONAL
Enrollment

25,000

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2030

Study Completion Date

October 30, 2030

Conditions
Respiratory Infection VirusCOVID -19RSVFLU
Interventions
OTHER

Component A0

It will be implemented as a recruitment strategy. This strategy will enable members of the community to access no cost testing for respiratory infections. If a participant feels sick or thinks they have been exposed to a respiratory infection and wants to be tested, they can complete a symptoms and exposure survey in the PREVENT APP, retrieve a PCR test kit from a vending machine using a unique code received through the PREVENT APP, self-collect an anterior nares nasal swab following instructions provided, and return the test kit at one of the vending machines or drop off locations for the EXCITE lab to pick up and process. The anterior nares nasal swab will be tested for SARS-CoV-2, influenza, Respiratory Syncytial Virus, and other germs (viruses or bacteria) that cause respiratory infections. At the time of consent and registration for the Community Testing Component, participants will be used to screen for Cohorts A/B.

OTHER

Component A1

Participants will be invited to 'test' out the PREVENT App and a provide a 'baseline' sample to ensure competency for requesting a nasal swab, retrieving the test kit from a vending machine, self-collecting a sample, and returning the test for PCR testing, with the assistance of study staff. Weekly Symptom Surveys, Annual Surveys, and immunization status.

OTHER

Component A2

Investigators will collect immunologic specimens from a subset of participants in Component A (the subset herein referred to as Component A immunologic sub-study). Investigators will combine testing data from these immunologic specimens with multiple data elements already captured in Component A (such as data from pathogen testing and sequencing, survey data, medical records, or immunization services) and Component B (serum obtained at enrollment and 28 post-enrollment) to meet sub-study objectives. Overall, the Component A sub-study will provide critical insight into the immune response to respiratory pathogen infections and immunizations.

OTHER

Component B

"Participants will be asked to complete the enrollment survey after enrolling in Component B if the survey has not already been completed as part of Component A. They will also be asked to complete:~1. Daily anterior nares nasal swab collection~2. All household participants, including the index case, will be asked to self-collect an enrollment swab and daily nasal swab specimens for 14 days and return them for testing.~3. Mucosal specimen collection~4. Survey data collection"

Trial Locations (2)

92093

UC San Diego, La Jolla

92173

San Ysidro Health, San Ysidro

All Listed Sponsors
collaborator

San Ysidro Health Center

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

University of California, San Diego

OTHER

NCT07147517 - Preparedness Through Respiratory Virus Epidemiology and Community Engagement | Biotech Hunter | Biotech Hunter